Notice: register_sidebar was called incorrectly. No id was set in the arguments array for the "Pages" sidebar. Defaulting to "sidebar-1". Manually set the id to "sidebar-1" to silence this notice and keep existing sidebar content. Please see Debugging in WordPress for more information. (This message was added in version 4.2.0.) in /home/mw6ws2rtlx4s/public_html/wp-includes/functions.php on line 5663

Warning: Undefined array key 0 in /home/mw6ws2rtlx4s/public_html/wp-content/plugins/wordpressdeploy/wpdeploy.php on line 504
avclark « Drive

Small-Molecule Therapeutics against Priority Myxovirus Pathogens

Drug development venture links translational research, business to launch new therapeutics

Emory University today announced an innovative new public-private drug development enterprise that will transition scientific discoveries more rapidly and efficiently from university laboratories into the marketplace. The new venture is expected to provide global solutions to address worldwide drug development and commercialization needs. Drug Innovation Ventures at Emory, LLC (DRIVE) is a not-for-profit company separate from, but wholly owned by Emory. DRIVE will expand the capabilities of traditional academic drug research by combining the expertise of Emory scientists and their unprecedented record of innovation and success in drug discovery with a world-renowned development, business and management team of industry leaders. DRIVE will provide the financial, business, project management and regulatory expertise to effectively move drugs through lead optimization and pre-clinical testing — a stage of drug development often termed the “Valley of Death” — and into proof-of-concept clinical trials. Technologies with added value can then be out-licensed to pharmaceutical and biotechnology companies, partnered with foundations or government entities, or spun-out...Read More >